Vidya Raman-Tangella - May 1, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol: TDOC
Transactions as of: May 1, 2024
Transactions value $: -$46,831
Form type: 4
Date filed: 5/2/2024, 04:05 PM
Previous filing: Mar 20, 2024
Next filing: Jun 4, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+10.2K	+45.31%		32.9K	May 1, 2024	Direct	F1
transaction	TDOC	Common Stock	Sale	-$46.8K	-3.69K	-11.24%	$12.69	29.2K	May 2, 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-10.2K	-20%	$0.00	41K	May 1, 2024	Common Stock	10.2K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	On May 1, 2022, the reporting person was granted 122,927 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.